GHK-CU 50mg

GHK-CU 50mg Research Peptide UK

GHK-CU 50mg (Glycyl-L-Histidyl-L-Lysine:Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It consists of three amino acids (Gly-His-Lys) coordinated with a copper ion (Cu2+), with molecular formula C14H23CuN6O4 and a molecular weight of 403.92 g/mol. As a ghk-cu 50mg research peptide, it is among the most extensively characterised small peptides in published literature, with genome-wide studies documenting interactions affecting the expression of over 4,000 human genes across tissue remodelling, stem cell signalling, inflammatory regulation, and antioxidant pathways.

Primary research areas where ghk cu research has documented preclinical data include collagen synthesis modulation in fibroblast cell models, extracellular matrix (ECM) research covering fibronectin and glycosaminoglycan production, antioxidant signalling through SOD and catalase pathways, wound biology assays examining wound closure markers and tissue remodelling, and stem cell differentiation biology. The breadth of the gene expression profile makes GHK-CU one of the most versatile small peptide research tools for cellular biology investigation across multiple disciplines.

GHK-CU 50mg is the entry format for copper peptide research, appropriate for pilot investigations, focused experimental series, gene expression screening studies, and first-time GHK-CU research. For high-throughput programmes, institutional research, or multi-researcher settings requiring extended single-batch consistency, GHK-CU 100mg provides the advanced format with equivalent purity and identical mechanism.

In skin and cellular biology research, GHK-CU 50mg and BPC-157 10mg are mechanistically complementary. GHK-CU operates through copper chaperone activity and ECM pathway interactions; BPC-157 operates through the nitric oxide pathway and VEGF signalling. These distinct mechanisms allow both compounds to be used as independent variables in the same cellular model, providing mechanistically non-overlapping research probes within the same experimental system.

Full mechanism detail, gene expression data, and protocol guidance are available in the GHK-CU 50mg research guide on the Ascend Peptides UK blog.

All batches tested by Janoshik. HPLC greater than or equal to 98%. LC-MS confirmed at C14H23CuN6O4, 403.92 g/mol.

For laboratory handling purposes, GHK-Cu may be reconstituted using sterile aqueous solutions such as bacteriostatic water or saline, depending on experimental requirements.

DISCLAIMER: For in-vitro research only. Not an MHRA-licensed medicine.